Recent News

• 11.13.2025 - MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
• 11.10.2025 - MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
• 10.07.2025 - MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
• 08.14.2025 - MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
• 08.14.2025 - MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
• 08.14.2025 - MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Recent Filings

• 11.13.2025 - 8-K Current report
• 11.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2025 - EX-99.1 EX-99.1
• 11.10.2025 - EX-99.1 EX-99.1
• 11.10.2025 - 8-K Current report
• 10.21.2025 - 144 Report of proposed sale of securities
• 10.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2025 - 144 Report of proposed sale of securities